The impact of antiplatelet and antithrombotic regimen after TAVI: Data from the VIenna CardioThOracic Aortic Valve RegistrY (VICTORY).
Markus MachVictoria WatzalCarina CuhajWaseem HasanThomas PoschnerPhilipp SzalkiewiczAndreas StrouhalChristopher AdlbrechtGeorg Delle-KarthMartin GrabenwögerBernhard WinklerPublished in: European journal of clinical investigation (2021)
The lower all-cause mortality for DAPT within the first year and N-VKAs over VKA within the first 3 years warrant considerable attention in further recommendations of antithrombotic and anticoagulation regimens after TAVI.
Keyphrases
- aortic valve
- atrial fibrillation
- transcatheter aortic valve implantation
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve replacement
- working memory
- electronic health record
- antiplatelet therapy
- clinical practice
- heart failure
- venous thromboembolism
- percutaneous coronary intervention
- acute coronary syndrome
- data analysis
- deep learning
- left ventricular
- artificial intelligence